|
TMEM161B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.101000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.715000E-01 |
| Normal-vs-Stage2 |
9.879200E-01 |
| Normal-vs-Stage3 |
5.728000E-01 |
| Normal-vs-Stage4 |
3.566000E-01 |
| Stage1-vs-Stage2 |
4.666200E-01 |
| Stage1-vs-Stage3 |
9.264800E-01 |
| Stage1-vs-Stage4 |
2.632000E-01 |
| Stage2-vs-Stage3 |
6.372400E-01 |
| Stage2-vs-Stage4 |
3.580400E-01 |
| Stage3-vs-Stage4 |
2.845600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.173800E-01 |
| Normal-vs-AfricanAmerican |
7.641800E-01 |
| Normal-vs-Asian |
3.971200E-01 |
| Caucasian-vs-AfricanAmerican |
7.905200E-01 |
| Caucasian-vs-Asian |
3.335800E-01 |
| AfricanAmerican-vs-Asian |
3.626800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.493400E-01 |
| Normal-vs-Female |
8.332800E-01 |
| Male-vs-Female |
2.762800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.857600E-01 |
| Normal-vs-Extreme_Weight |
3.386000E-01 |
| Normal-vs-Obese |
5.272800E-01 |
| Normal-vs-Extreme_Obese |
9.820000E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.835200E-01 |
| Normal_Weight-vs-Obese |
8.501200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.073800E-01 |
| Extreme_Weight-vs-Obese |
7.372800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.605000E-01 |
| Obese-vs-Extreme_Obese |
8.325400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.977200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.279000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.277400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.627200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.023200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.085400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.265220E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.161400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.267500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.709000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.472760E-01 |
| Normal-VS-Type2 PRCC |
4.888000E-01 |
| Normal-VS-KIRP CIMP |
2.880800E-01 |
| Normal-VS-Unclassified PRCC |
8.987600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.664200E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.144800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.139400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.274000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.643800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.386800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.602400E-01 |
| Normal-vs-N1 |
6.608200E-01 |
| Normal-vs-N2 |
9.438000E-01 |
| N0-vs-N1 |
3.676400E-01 |
| N0-vs-N2 |
7.629400E-01 |
| N1-vs-N2 |
8.310400E-01 |
|
|
